Abstract:Sphingosine, an amphiphilic molecule, plays a pivotal role as the core structure of sphingolipids, essential constituents of cell membranes. Its unique capability to enhance the permeability of lipid membranes profoundly influences crucial life processes. The molecular structure of sphingosine dictates its mode of entry into lipid bilayers and governs its interactions with lipids, thereby determining membrane permeability. However, the incomplete elucidation of the relationship between the molecular structure of sphingosine and the permeability of lipid membranes persists due to challenges associated with synthesizing sphingosine molecules. A series of sphingosine-derived molecules, featuring diverse hydrophobic chain lengths and distinct headgroup structure, were meticulously designed and successfully synthesized. These molecules were employed to investigate the permeability of large unilamellar vesicles, functioning as model lipid bilayers. With a decrease in the hydrophobic chain length of sphingosine from C15 to C11, the transient leakage ratio of vesicle contents escalated from ∼ 13 % to ∼ 28 %. Although the presence of double bond did not exert a pronounced influence on transient leakage, it significantly affected the continuous leakage ratio. Conversely, modifying the chirality of the C-3 hydroxyl group gives the opposite result. Notably, methylation at the C-3 hydroxyl significantly elevates transient leakage while suppressing the continuous leakage ratio. Additionally, sphingosines that significantly affect vesicle permeability tend to have a more pronounced impact on cell viability. Throughout this leakage process, the charge state of sphingosine-derived molecule aggregates in the solution emerged as a pivotal factor influencing vesicle permeability. Fluorescence lifetime experiments further revealed discernible variations in the effect of sphingosine molecular structure on the mobility of hydrophobic regions within lipid bilayers. These observed distinctions emphasize the impact of molecular structure on intermolecular interactions, extending to the microscopic architecture of membranes, and underscore the significance of subtle alterations in molecular structure and their associated aggregation behaviors in governing membrane permeability.

Tackling the biophysical properties of sphingolipids to decipher their biological roles

Sphingolipids and their metabolism in physiology and disease

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

Principles of bioactive lipid signalling: lessons from sphingolipids

Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology

Potential Therapeutic Targets for Atherosclerosis in Sphingolipid Metabolism

Regulation of cellular and systemic sphingolipid homeostasis

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Sphingolipids and Mitochondrial Dynamic

Conserved function of ether lipids and sphingolipids in the early secretory pathway

Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?

Bioactive sphingolipids as emerging targets for signal transduction in cancer development

Why do we study sphingolipids?

Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

Modulating lipid bilayer permeability and structure: Impact of hydrophobic chain length, C-3 hydroxyl group, and double bond in sphingosine

Sphingolipid Analysis in Clinical Research

Modulation of protein kinase C and diverse cell functions by sphingosine--a pharmacologically interesting compound linking sphingolipids and signal transduction

Atypical sphingosine-1-phosphate metabolites-biological implications of alkyl chain length

Perspective: Therapeutic Implications for Sphingolipids in Health and Disease

Sphingolipid metabolism and signaling in cardiovascular diseases

Sphingomyelin and Its Role in Cellular Signaling.